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Abstract
Background: The most frequent pathogen that causes bacterial meningitis is the Gram-positive bacterium
Streptococcus (S.) pneumoniae. CCAAT/enhancer binding protein δ is a transcription factor that has recently been
hypothesized to play a detrimental role in outcome of meningitis caused by S. pneumoniae. Here, we studied the
role of C/EBPδ prior to the development of pneumococcal meningitis.
Methods: Wild-type and C/EBPδ-deficient mice (C/EBPδ−/−) were intraveneously infected with S. pneumoniae and
sacrificed after 24 or 48 h. cebpδ expression, bacterial loads, inflammatory response and pathology in the brain
were assessed.
Results: S. pneumoniae induces cebpδ expression in the brain during blood-borne brain infection. In comparison to
wild-type mice, C/EBPδ−/− animals showed decreased bacterial loads in blood and brain 48 h after inoculation.
In the blood compartment, the host inflammatory response was significantly lower upon infection in C/EBPδ−/−
mice as compared to wild-type mice.
Conclusion: C/EBPδ facilitates bacterial dissemination to the brain and enhances the immune response in the
blood compartment. Our study suggests that C/EBPδ plays a detrimental role during the initial development of
blood-borne brain infection.
Keywords: CAAT/enhancer-binding protein δ, C/EBPδ, Blood-borne brain infection, Streptococcus pneumoniae,
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Background
The Gram positive bacterium Streptococcus (S.) pneumo-
niae is a common colonizer of the respiratory tract [1].
S. pneumoniae can however become invasive and may
spread from the upper respiratory tract to other organs,
leading to life-threathening infections such as pneumo-
nia, sepsis, or meningitis [2]. Meningitis is a disease of
the central nervous system characterized by inflamma-
tion of the protective membranes covering the brain and
spinal cord [3]. S. pneumoniae is the most common
etiological agent of bacterial meningitis and causes 70 %
of cases [4–6]. Despite the availability of effective anti-
biotic treatments and vaccination programs [7, 8],
bacterial meningitis still has a high mortality rate in
adult patients and almost half of survivors suffer from
neurological sequelae (e.g., learning, hearing, and mem-
ory impartment, seizures, and motor deficits) due to per-
manent brain damage [6, 9–15]. Consequently, it is
essential to improve existing therapies for meningitis
through improving our understanding of the underlying
pathophysiology.
CCAAT/enhancer binding protein (C/EBP) δ is a mem-
ber of the C/EBP family of transcription factors that
currently is composed of 6 different unique members (C/
EBPα, C/EBPβ, C/EBPδ, C/EBPγ, C/EBPε and C/EBPζ)
[16, 17]. C/EBPδ is generally accepted to act as a pro-
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inflammatory transcription factor, and was found to be
essential in Fcγ receptor-mediated inflammatory cytokine
and chemokine production. C/EBPδ deficient macro-
phages failed to induce a full tumour-necrosis factor
(TNF)-α, macrophage inflammatory protein (MIP)-2 and
MIP-1α response induced by IgG Immune complexes
[18]. Moreover, low dose lipopolysaccharide (LPS) stimu-
lation of macrophages induces C/EBPδ expression, leading
to higher interleukin (IL)-6, Monocyte Chemoattractant
Protein (MCP)-1 and endothelin-1 levels [19]. C/EBPδ
also potentiates IL-6 expression in macrophages upon
high dose LPS stimulation [20]. Recently, C/EBPδ was
shown to play a pivotal role in the host response to gram-
positive S. pneumoniae infections including pneumonia
and meningitis [21, 22]. During pneumococcal pneumo-
nia, C/EBPδ exaggerates bacterial dissemination and wild-
type mice succumb earlier to the disease as compared to
C/EBPδ−/− mice whereas in pneumococcal meningitis in-
creased C/EBPδ expression in the brain was associated
with increased bacterial growth, dissemination and the
inflammatory response.
Most in vivo models that study the pathophysiology of
bacterial meningitis involve the direct injection of
pneumococci into the brain of mice or rats [23] and
therefore aim to study host-pathogen interactions once
infection is established in the meninges. The aim of the
current study was to investigate the role of C/EBPδ prior
to the onset of meningitis. Since an important route of
central neurvous system (CNS) infection by bacterial
pathogens is via the blood stream, we challenged wild-
type and C/EBPδ−/− mice with S. pneumoniae through
intravenous injections. We show that S. pneumoniae in-
duces C/EBPδ expression in the brain in blood-borne
brain infection. Moreover, C/EBPδ−/− animals showed
decreased bacterial loads in blood and brain 48 h after in-
oculation. The reduced bacterial dissemination in the brain
did however not result in a lower inflammatory response
or reduced histopathology in the brain of C/EBPδ−/− mice.
Thus, our study suggests that C/EBPδ−/− modifies bacterial
dissemination in blood-borne brain infection.
Methods
Animals
C/EBPδ−/− mice, generated as described previously [24],
were backcrossed at least 10 times to a C57BL/6 back-
ground. Wild-type mice were purchased from Charles
River (Maastricht, the Netherlands). 8- to 12-week-old
male or female animals were maintained at the animal
facility of the Academic Medical Center (University of
Amsterdam) with free access to food and water. All
animal experiments were approved by the Institutional
Animal Care and Use Committee of the Academic Med-
ical Center, University of Amsterdam.
Sepsis infection model
Wild-type and C/EBPδ−/− mice (n = 30 per group) were
inoculated into the tail vein with 5 × 105 CFU of S. pneu-
moniae serotype 3, American Type Culture Collection
65303 (in 200 μl saline) as previously described [25, 26].
Control animals (n = 6) received saline only. At 24 h and
48 h after inoculation, organs were collected and homoge-
nised as described previously [27].
Determination of cytokines and chemokines
TNF- α, IL-6, Interferon (IFN)-γ and MCP-1 levels were
determined using a cytometric bead array multiplex
assay (BD Bioscience, San Jose, CA, USA) as described
previously [27].
Real-time PCR
Total RNA was extracted from murine brain homogenates
using TriPure reagent (Sigma-Aldrich, St-Louis, MO,
USA). For complementary DNA (cDNA) synthesis, RNA
was treated with RQ1 RNase-free DNase (Promega,
Leiden, the Netherlands) and reverse transcribed with
SuperScript II Reverse Transcriptase and random hexam-
ers (Life Technologies, Bleiswijk, the Netherlands). The
real-time polymerase chain reaction (RT-PCR) was per-
formed on a Bio-Rad MyiQ Single-Color RT-PCR Detec-
tion System using the Bio-Rad iQ SYBR Green Supermix
(Bio-Rad Laboratories, Hercules, CA, USA). The c/ebpδ
and Non-POU-domain containing octamer binding pro-
tein (NoNo, housekeeping gene), primers were described
previously [22]. The C/EBPδ expression levels were nor-
malized to the NoNo reference gene.
A negative control without the Reverse Transcriptase
was also used.
Statistical analysis
All data are expressed as means ± SEM. Differences be-
tween groups were analyzed by t-test and when neces-
sary corrected for nonparametric values by Mann-
Whitney U test. Differences in bacteremic brains were
analysed by Fisher’s exact test. Correlation was analysed
by correlation analysis. Analyses were performed
using GraphPad Prism version 6.0 (GraphPad Soft-
ware, San Diego, CA, USA) or R [28]. Statistically sig-
nificant differences were considered with a p value
less than 0.05.
Results
C/EBPδ expression is increased in brain during
pneumococcal sepsis
To determine C/EBPδ expression in the brain during
sepsis caused by S. pneumoniae, we measured c/ebpδ
mRNA levels in brain tissue from wild-type mice inocu-
lated with 5 × 105 collony forming units (CFU). As
shown in Fig. 1a, c/ebpδ mRNA levels were low in brain
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of uninfected mice but significantly increased at 24 h
(approximately 3-fold) and 48 h (approximately 10-fold)
after S. pneumoniae inoculation.
C/EBPδ aggravates bacterial dissemination from the
blood to the brain
In order to investigate the role of C/EBPδ in the develop-
ment of meningitis upon pneumococcal sepsis, wild-type
and C/EBPδ−/− mice were intravenously inoculated with S.
pneumoniae. Over time the bacterial loads increased in
wild-type mice in blood, brain and lung. After 48 h, C/
EBPδ−/− mice had significant lower bacterial count in the
blood as compared to wild-type (Fig. 1b). As shown in
Fig. 1c, C/EBPδ−/− mice also presented lower bacterial
counts in the brain as compared to wild-type mice 48 h
after inoculation. Notably, the number of mice with
bacteremic brains was increased in wild-type mice at 48 h
(14/29 versus 5/28, p = 0.02, odds ratio [OR] 4.2, 95 %
confidence interval [CI] 1.13–18.1), whereas the number
was similar in C/EBPδ−/− mice at 24 h (7/29 versus 4/30,
p = 0.33, OR 2.04, CI 0.45–10.83). No difference was
observed in bacterial counts in the lungs of wild-type
and C/EBPδ−/− mice (Fig. 1d). Correlation analysis of
cebpd mRNA expression and bacterial loads in the
brain shows that C/EBPδ expression is positively and
significantly correlated with the bacterial burden (p = 0.01,
Fig. 1 C/EBPδ is detrimental for the blood-brain barrier upon intravenous pneumococcal infection. c/ebpδ mRNA (a) in wild-type brain tissue at
different time points after intravenous inoculation with S. pneumoniae. Bacterial outgrowth in whole blood (b), brain (c) and lung (d) of wild-type
and C/EBPδ−/− 24 and 48 h after infection. Correlation analysis of cebpd mRNA expression and bacterial loads in the brain (e). Data are expressed
as scatter dot plots with the median (n = 6 for controls; n = 30 at both t = 24 and t = 48 h post infection). * P < 0.05, ** P < 0.01, *** P < 0.001
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Spearman r = 0.68; Fig. 1e), suggesting that the increase in
C/EBPδ expression leads to bacterial dissemination.
C/EBPδ does not affect the inflammatory response in
brain during pneumococcal sepsis
To determine whether C/EBPδ affects the inflammatory
response in blood and brain during pneumococcal sepsis
we measured different cytokine and chemokine levels in
plasma and brain homogenates. As shown in Fig. 2, the
host response as measured by cytokine and chemokine
production in plasma was increased over time in both
wild-type and C/EBPδ−/− mice. IL-6 levels (Fig. 2a) were
significantly lower at both 24 and 48 h post inoculation
in C/EBPδ−/− mice as compared to wild-type mice. IFN-
γ (Fig. 2d) and MCP-1 (Fig. 2b) levels were significantly
lower at 24 (IFN-γ) or 48 (MCP-1) hours post inocula-
tion. No differences in TNF-α levels were observed be-
tween wild-type and C/EBPδ−/− mice (Fig. 2c). In brain,
all measured cytokine and chemokine levels were very
low (data not shown) and histological analysis of the
brains did also not show clear signs of meningitis (data
not shown).
Discussion
In the present study, we demonstrate that C/EBPδ plays
a detrimental role during S. pneumoniae sepsis-induced
meningitis. We show that C/EBPδ expression in the
brain is induced after an intravenous challenge with S.
pneumoniae, and that it aggravates bacterial dissemin-
ation from the blood to the brain thereby driving the
progression towards meningitis. This notion is strength-
ened by the positive correlation between C/EBPδ gene
expression levels and bacterial counts in the brain 48 h
post challenge.
Several studies have implicated C/EBPδ as regulator of
proinflammatory cytokine expression [29], which are in line
with our finding that 24 h after inoculation, IL-6 and INF-γ
levels in plasma were significantly lower in the absence of
C/EBPδ; and at 48 h post challenge, IL-6 and MCP-1 levels
were lower in C/EBPδ−/− mice. However, we were not able
to detect differences in cytokine levels between groups in
the brain compartment since pneumococcal sepsis only
caused a very modest inflammatory response in the brain,
as reflected by low inflammatory cytokine levels. In accord-
ance with the inflammatory cytokine profile in brain, the
absence of brain histopathological meningitis traits, even at
48 h, indicates that the experimental model is merely suit-
able to study the initial process of the development of
pneumococcal meningits. Because the mice eventually will
start to clear the bacteria shortly after 48 h post inoculation,
the sepsis model used is not suitable to study prolonged
time points beyond 48 h which is a limitation of our study.
Fig. 2 C/EBPδ affects the inflammatory response in plasma in pneumococcal blood-borne brain infection. Levels of IL-6 (a), MCP-1 (b), TNF-α (c)
and IFN-γ (d) in plasma of Wild-type and C/EBPδ −/− mice in S. pneumoniae blood-borne brain infection. Data are expressed as scatter dot plots
with the median (n = 6 for controls; n = 30 at both t = 24 and t = 48 h post infection). # P = 0.054, * P < 0.05, **** P < 0.0001
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In addition to the difference in bacterial loads in the
brain we did not observe a difference in dissemination
towards the lungs. This is in line with our previous study
[21] in which we specifically studied the role of C/EBPδ
in S. pneumoniae-induced pulmonary infection. In the
previous study we did not observe a difference in bacter-
ial loads in the blood of wildtype and C/EBPδ−/− mice,
which is in contrast with the current study where we did
observe a difference in bacterial loads in the blood at
48 h post inoculation. The discrepancy between the two
studies may be caused by the number of mice included.
The number of mice included in the current study is ap-
proximately four times higher (8 versus 30 for the previ-
ous study and the current study respectively) which may
have increased the power of the statistical analysis lead-
ing to a significant difference in the current study. More
importantly however, the lack of a significant difference
in dissemination towards the lungs suggests that the
observed difference in bacterial loads in the brain be-
tween wildtype and C/EBPδ−/− mice in the current
study is not merely a reflection of the bacterial loads in
the blood. Therefore we conclude that C/EBPδ plays a
specific role in the dissemination of S. pneumoniae to-
wards the brain.
Previously we have shown that upon intracisternal in-
oculation of pneumococci, C/EBPδ−/− mice showed a de-
crease in bacterial outgrowth and inflammatory response
in the brain as compared to wild-type mice [22]. Here we
show that C/EBPδ−/− mice have limited bacterial dissem-
ination towards the brain upon intravenous inoculation of
pneumococci. Taken together, these results show that C/
EBPδ plays a dual and detrimental role during both the es-
tablishment and disease progression of pneumococcal
meningitis. It can therefore be speculated that inhibition
of C/EBPδ may reduce bacterial dissemination during
both the establishment and subsequent progression of
pneumococcal meningitis. However, further studies
should elucidate the role of C/EBPδ as potential target
for novel therapeutic interventions during meningitis.
Conclusions
Our results show that C/EBPδ expression in the brain
increased in response to systemic S. pneumoniae infec-
tion, that C/EBPδ−/− mice presented reduced bacterial
dissemination to the brain and displayed a lower inflam-
matory response in plasma as measured by MCP-1 and
IL-6. Overall, our results show that C/EBPδ plays a
detrimental role during the initial development of men-
ingitis caused by sepsis.
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